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All A/J  mice  immunized  with  keyhole  limpet  hemocyanin-p-azophenylarsonate 
(KLH-Ar)  t produce anti-Ar antibodies with shared idiotypic specificity, as shown by 
the capacity of each immune serum to displace radiolabeled anti-Ar antibody of  an 
individual A/J mouse from its rabbit antiidiotypic antibodies (1, 2). The IgG fraction 
of rabbit antiidiotypic antibody (anti-D), when inoculated intraperitoneally in saline 
solution into an adult or neonatal A/J mouse, suppresses the appearance of the cross- 
reactive idiotypic specificity, although substantial amounts of non-cross-reactive anti- 
Ar antibodies are produced in all mice (2, 3).2 
In our previous experiments almost complete suppression persisted for up to 5 mo in 
the surviving mice. However, interpretation of these results in terms of the true dura- 
tion of effective suppression is complicated because immunization was initiated only 
2-9 wk after administration of the antiidiotypic antibody. Since antihapten antibody 
(not idiotypically  cross-reactive) was produced as a result of such immunization, it is 
conceivable that members of the responsible clones of cells might capture antigen sub- 
sequently administered and in this way prevent the expression of the idiotype by any 
appropriate precursor ceils that might have arisen subsequent to the first challenge by 
antigen. 
To  investigate  this possibility we  have  carried  out  a  series of  experiments 
with  adult A/J  mice, in which  the initial inoculation of antigen was given  at 
increasing intervals after immunosuppression, and have measured the duration 
of suppression under these conditions. The minimum quantity of antiidiotypic 
IgG required for suppression of idiotype was measured and suppressive effects 
of Fab' and  F(abt)2 fragments  of rabbit  antiidiotypic IgG were  investigated. 
The  extent  of  suppression  by antiidiotypic antibody,  when  administered  to- 
gether with or subsequent  to antigen, was also determined. 
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1 A bbrevlations used in this paper: anti-D, antiidiotypic  antibody; Ar, p-azophenylarsonate; 
BGG, bovine  gamma globulin;  BSA, bovine  serum  albumin; CRI, cross-reactive  idiotype; 
KLH, keyhole limpet hemoeyanin. 
2 Individual, suppressed  A/J mice synthesize  anti-Ar antibodies which do not share idio- 
typic specificity; i.e., unique specificitles are present in each suppressed  mouse  (4). 
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Materials and Methods 
Methods Previously Described.--The  following methods have been described (1, 2) : hyper- 
immunization of mice with protein-p-azophenylarsonate conjugates; specific purification of 
mouse antihapten antibodies, employing a protein carrier other than that used for the immuni- 
zation; preparation of rabbit antiidiotypic antiserum by immunization with a dissolved specific 
precipitate made with mouse anti-At antibody and (bovine gamma globulin) B GG-Ar; absorp- 
tion of the antiserum with A/J serum and A/J serum globulins; adsorption of an IgG fraction 
of anti-D serum with Sepharose to which a crude globulin fraction (18% sodium sulfate pre- 
cipitate) of A/J serum had been conjugated; labeling of purified anti-Ar antibodies with 1251 
by the chloramine-T method (5) ; removal of antihapten antibodies from antisera with an im- 
munoadsorbent (Sepharose 4 B coupled to rabbit IgG-Ar) ; determination of the concentration 
of precipitable anti-p-azophenylarsonate antibodies in hyperimmune sera; quantification of the 
125I-labeled  anti-At antibody reactive with antiidiotypic antibody by a  method of indirect 
precipitation; quantification of cross-reacting idiotypic antibodies present in various unlabeled 
sera by measurement of their capacity to inhibit the indirect precipitation of labeled ligand. 
In brief, the latter method consists in mixing 0.01 #g of 125I-labeled specifically purified anti-At 
antibody of mouse 126 with slightly less than an optimal amount of antiidiotypic antiserum 
(5 #1 of an 1 : 10 dilution in a solution containing bovine serum albumin [BSA])  (1  mg/ml in 
NaCl-borate buffer, pH 8, ionic strength 0.15). To this mixture is added 25 #1 of a  1:10 dilu- 
tion of rabbit antiovalbumin. Mter incubating for 1 h at 37°C, an excess (75 #1) of goat anti- 
serum specific for rabbit Fc is added to precipitate rabbit IgG and complexes of the labeled 
ligand with rabbit antiidiotypic antibody. Unlabeled inhibitors, when present, are mixed with 
the antiidiotypic antiserum 15 min before the addition of  the  125I-labeled  purified anti-Ar 
antibody. 
The BSA is used to provide a moderately high protein concentration and thus to retard de- 
naturation of the highly dilute labeled anti-At antibody. Rabbit antiovalbumin is  added so 
that the total concentration of rabbit IgG is sufficient to yield a heavy precipitate upon  sub- 
sequent addition of goat anti-Fc. 
Each set of experiments included controls in which additional rabbit antiovalbumin was 
substituted  for  the  anfiidiotypic antiserum.  The  percentage  of  radioactivity precipitated 
(8-12°/~) was subtracted from experimental values. In the absence of inhibitor 43-54% of the 
labeled ligand (net value) was precipitated.  (Less than an optimal amount of anti-D is used 
to make inhibition tests more sensitive. With excess anti-D approximately 70% of the ligand 
is precipitated.) Another test of specificity was carried out by using 125I-labeled  nonspecific 
A/J IgG in place of the labeled anti-Ar antibody; 10% of the radioactivity was precipitated. 
Inoculation  of Mice with  Antiidiotypic  Antibody.--In  experiments designed  to  suppress 
idiotypic specificity, mice were inoculated with a saline solution of an IgG fraction of the anti- 
idiotypic antiserum, adsorbed with Sepharose conjugated to a crude globulin fraction of A/J 
serum.  The  saline solution was  sterilized  by passage  through a  Millipore filter  (Millipore 
Corp., Bedford, Mass.). Binding tests were carried out with anti-D antiserum that had been 
absorbed by addition of A/J serum and A/J IgG (1). 
For t.hose studies whose results are summarized in Tables I  and II, the antiidiotypic IgG 
was administered intraperitoneally; in the remainder of the experiments it was given subcu- 
taneously. That either route is effective in suppressing idiotype had been observed in pre- 
liminary experiments and is illustrated in data presented below. 
An IgG fraction of the adsorbed antiidiotypic antiserum or of the normal rabbit antiserum 
was  prepared  by  two  precipitations with  sodium  sulfate followed  by chromatography on 
DEAE-cellulose in 0.0175 M  phosphate buffer, pH 6.9.  F(ab0 2 fragments were prepared by 
digestion with pepsin for 4 h at 37°C, followed by gel filtration (6). Fab  ~  fragments were pro- 
duced by reduction of F(ab')2 with 0.007 M  dithiothreitol, followed by gel filtration. Both 
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contamination by undegraded IgG was demonstrated by trace-labeling each preparation with 
125I and gel filtering in the presence of excess rabbit IgG. Nearly all of the radioactivity was 
eluted from the column after the peak of optical density corresponding to IgG. The degree 
of contamination by IgG was less than 2% for each of the four preparations [F(ab') z and Fab  I 
frmn antiidiotypic or normal serum]. 
RESULTS 
Evidence for A ntiidiotypic Specificity  of the Absorbed Rabbit A ntiserum.--Evi- 
dence  that  the  absorbed  rabbit  antiserum  directed  to  anti-Ar  antibodies  of 
mouse 126 is specific for idiotypic determinants has been reported elsewhere (3, 
7). In brief, the indirect precipitation of 0.01 ~g of the 12~I-labeled mouse anti-Ar 
antibody by antiidiotypic antibody was inhibitable by the hyperimmune donor 
serum but not by preimmune donor serum nor by hyperimmune donor serum 
from which the antihapten antibody had been specifically adsorbed. Antibodies 
to the carrier protein (KLH) or anti-KLH-p-azobenzoate antibodies prepared 
in other A/J mice were noninhibitory. Up to 2 nag of A/J anti-KLH antibodies 
and nonspecific A/J IgG caused less than 25 % inhibition of binding. By com- 
parison, 0.02/~g of unlabeled autologous antibody was sufficient to cause 66 % 
inhibition. 
Duration  of Suppression of Idiotype.--Tables I  and II present data relating 
to the duration of suppression of the cross-reactive idiotype (CRI). Each value 
in Tables I  and II represents an individual mouse. Each mouse received 4 mg 
of an IgG fraction of the adsorbed rabbit antiidiotypic antiserum or, as a con- 
trol, 4  mg of nonspecific IgG. At  the end of the desired interval, mice were 
challenged with  500 #g  of KLH-Ar in  Freund's complete adjuvant,  injected 
intraperitoneally (i.p.) ; this was repeated 2 wk later. After another 2 wk inter- 
val,  500  b*g of the  same  antigen  was  inoculated  i.p.  in  Freund's  incomplete 
adjuvant. Bleedings were taken 1 wk after the second and third injections. The 
time periods specified in the tables (i.e. 2, 6, 12, and 20 wk) refer to the interval 
between the inoculation of the  antiidiotypic or nonspecific IgG and  the first 
challenge with  antigen.  CRI  was  quantified  by determining  the  capacity of 
varying amounts of serum to inhibit the binding of 0.01 ~g of 125I-labeled anti-Ar 
antibody of mouse 126 to its antiidiotypic antibodies. Mice designated with the 
prefix C (control) were inoculated with nonspecific IgG; those with the prefix S 
(suppressed) were treated with antiidiotypic IgG. 
In all experiments the control mice, inoculated with nonspecifie IgG and challenged with 
KLH-Ar, produced high concentrations of idiotypically cross-reactive antibody, which was 
present in both the first and second bleedings. As little as 0.03 ~zl of each antiserum was suffi- 
cient to cause 60% inhibition, with most values around 80%.  Equal volumes of preimmune 
sera from the mice in each of the four control groups were then pooled. 10 #1 of pooled preim- 
mune serum failed to cause significant inhibition of binding (less than 7%) in each case. This 
is in accord with previous results (2). 
The sera of mice challenged with antiidiotypic IgG and then, beginning 2 wk later, with 
KLH-Ar, contained virtually no CRI in either bleeding. 10 #1 caused far less inhibition than 
0.03/~I of sera from control mice; thus, the ratio is greater than 300 to I. TABLE  I 
Inhibition  of Binding  of 125I-Labeled Anti-Ar Antibody from  Mouse 126 to its Rabbit 
Antiidiotypic Antibodies* 
Interval between 
Inhibitor  suppression and 
(mouse no.)  first antigen 
challenge 
125I-labeled purified anti-Ar antibody bound (% of control) 
First bleeding  Second bleeding 
/zl of serum tested as inhibitor 
0.1  3  10  0.03  0.1  3 
C-100~  2 wk  41  25  6  0 
C-101  35  22  24  0 
C-102  24  26  15  10 
C-103  14  28  7  1 
C-104  38  40  25  2 
C-105  37  35  23  12 
C-106  28  24  18  6 
C-107  24  23  18  13 
C-108  27  30  18  9 
C-109  20  22  15  8 
S-80~  2 wk  98  98  96  94 
S-81  98  97  96  94 
S-82  97  98  94  93 
S-83  96  99  98  93 
S-84  101  99  98  94 
S-85  97  99  97  93 
S-87  98  98  98  96 
S-89  102  99  99  94 
S-121  92  98  96  92 
S-122  77  94  81  75 
C-201  6 wk  40  20  7 
C-202  15  24  18 
C-203  2O  26  15 
C-204  24  35  22 
C-205  30  28  17 
C-206  37  22  12 
S-140  6 wk  93  97  94  77 
S-141  97  90  95  90 
S-142  95  90  96  90 
S-143  83  82  82  75 
S-144  98  98  97  93 
S-145  86  79  78  74 
S-147  100  96  98  96 
S-148  98  92  98  90 
* In the absence of inhibitor, 46%  (net value) of the labeled ligand was bound. All experi- 
ments were carried out in duplicate. The average deviation from the mean, expressed as per- 
cent of control, was 1.6%. 
The letter C indicates a control mouse, which received 4 mg of nonspecific IgG. The letter 
S designates a  suppressed mouse, which had received 4 mg of antiidiotypic IgG. The protocol 
of immunization is given in the text. The nonspecific or antiidiotypic IgG was administered in- 
traperitoneally. 
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Inhibition  of Binding  of  12~I-Labeled Anti-Ar  Antibody from  Mouse  126  to  its  Rabbit 
Antlidiotypic  Antibodies* 
Interval between 
Inhibitor  suppression and 
(mouse no.)  first antigen 
challenge 
125 I-labeled purified D antibody bound (% of control) 
First bleeding  Second bleeding 
#1 of serum tested as inhibitor 
0.03  0.1  3  10  0.03  0.1  3  10 
C-11{  12 wk  40  8  2  42  5  0 
C-12  32  0  0  30  0  0 
C-13  33  2  0  §  §  § 
C-14  37  9  1  36  4  0 
C-15  35  7  4  38  4  6 
S-150{  12 wk  100  90  90  98  88 
S-151  97  85  83  §  § 
S-152  103  85  86  92  94 
S-153  37  0  0  27  0 
S-154  72  14  14  §  § 
S-155  76  50  48  42  0 
S-156  22  0  0  14  0 
S-157  27  0  2 
S-158  78  45  36 
82 
§ 
81 
0 
§ 
6 
0 
C-16  22 wk  49  18  §  §  § 
C-17  22  15  §  §  § 
C-18  44  9  §  §  § 
C-19  12  4  §  §  § 
c-20  27  7  §  §  § 
C-21  63  29  §  §  § 
C-22  0  0  35  19  3 
C-24  14  0  §  §  § 
C-25  6  0  §  §  § 
C-126  10  8  56  20  10 
C-127  20  0  §  §  § 
C-129  14  6  31  19  8 
S-161  22 wk  99  95  93  94 
S-162  6  0  8  0 
S-163  91  88  89  87 
S-165  93  90  83  34 
s-1  0  o  §  § 
S-3  73  45  §  § 
S-5  93  77  88  76 
S-6  0  0  4  0 
S-7  11  0  5  0 
S-8  11  0  §  § 
S-10  10  0  3  0 
* In the absence of inhibitor, 54%  (net value) of the labeled ligand was bound. All experi- 
ments were carried out in duplicate. The average deviation from the mean, expressed as per- 
cent of control, was 1.4%. 
:~ See second footnote, Table I. 
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6 wk after suppression, the amount of CRI produced upon challenge with KLH-Ar was 
similarly negligible in all mice (Table I). 
Data on suppression of idiotype, when the first challenge of antigen was de- 
layed until  12  or 22  wk after suppression,  are presented  in Table II. As evi- 
denced by the capacity of their antisera to inhibit the antiidiotypic antibody, all 
members of the control groups, which received nonspecific rabbit IgG, produced 
substantial  quantities  of the cross-reactive idiotype. In contrast,  12  wk after 
administration of antiidiotypic antibody, seven of nine surviving mice were at 
least partially suppressed at the time of the first bleeding; (cf. data obtained in 
the control and experimental groups with 0.1/zl of serunl as inhibitor). In five 
of the nine mice in the experimental group, the degree of suppression was almost 
complete at this time, as indicated by the small degree of inhibition of binding 
caused by 3/zl or 10/zl of serum. By the time of the second bleeding, only five 
mice  survived.  Two of  these  were  completely suppressed,  one  was partially 
suppressed, and two produced normal amounts of CRI. There was little change 
in the status of each of these five mice between the first and second bleedings. 
Of the group of mice that were first immunized 22 wk after treatment with 
antiidiotypic IgG, 5 of the 10 were almost completely suppressed with respect 
to  production  of idiotype  at  the  time  of  the  first bleeding,  whereas  5  mice 
showed no indication of suppression. At the time of the second bleeding, four 
of the eight surviving mice failed to produce CRI; the other four did not differ 
from the controls. There was no change in the status of individual mice between 
the first and second bleedings. 
Le~'els of A ntihapten Antibody in Control and Suppressed M ice.--Quantitative 
precipitin analyses were carried out to determine the concentration of precipit- 
able anti-Ar antibodies in the sera of control and suppressed mice subsequent to 
immunization with KLH-Ar. Sera of each group were pooled separately, using 
an equal  amount of antiserum from each mouse. The mice that made up the 
"suppressed" group included only those mice which failed to produce CRI (not 
those which did produce CRI despite the administration of anti-D  antibody). 
The test antigen used was BGG-Ar. Precipitin tests were carried out with five 
concentrations  of antigen;  the  curve went through  a  maximum in  each case. 
The methods used for quantitation  and for correcting for the antigen content 
in the precipitate have been described (1). 
The data are presented in Table III. It is evident that there were no signifi- 
cant differences between the control and suppressed groups at the time of the 
second bleeding.  The average titers in both groups, however, decreased with 
time. This may possibly be a function of the age of the mice. 
Effect of Dosage of Antiidiotypic  Antibody.--Varying amounts of antiidiotypic 
IgG were administered to four groups of mice (10 per group). 6 wk later the mice 
were challenged intraperitoneally with 500 >g of KLH-Ar in Freund's complete 
adjuvant.  2 wk and 4 wk later a  second and third injection were given in the 
same manner, except that Freund's incomplete adjuvant was used for the third 
inoculation. Bleedings were taken 1 wk after the second and third injections. 1448  R~EQUIREMENTS  t'OR  SUPPRESSION OF  IDIOTYPE 
TABLE III 
Concentration of Antf-Ar Antibodies in Mice Treated with Nonspecific or Antiidiotyplc IgG* 
Interval between  Precipltable anti-Ar 
suppression and first  Serum pool  no.  of mice  Immune status 
antigen challenge  antibody 
wk  mg/ml 
2  9  Control  5,8 
2  9  Suppressed  5.4 
12  4  Control  4. l 
t2  2  Suppressed  4.6 
22  3  Control  3.4 
22  3  Suppressed  3.7 
* Serum samples were pooled from bleedings taken after  two injections  of KLH-Ar in 
Freund's complete adjuvant. 
A  control group of mice was treated identically,  except that nonspecific IgG 
was injected in place of antiidiotypic IgG. The control mice in group 3, Table I, 
also served as controls for this experiment since they were inoculated with 4 mg 
of nonspecific IgG 6  wk before immunization,  and inmmnization  and bleeding 
of those mice were done in the same way. 
Of  the  group of mice pretreated  with  4  mg of  antiidiotypic  IgG,  all  seven 
survivors failed  to produce a  significant titer  of antibody-bearing  CRI  (Table 
IV). This result is in agreement with the data obtained with the other group of 
mice,  which  also  were  inoculated  with  4  mg  of  antiidiotypic  antibody  6  wk 
before immunization with KLH-Ar (Table I). 
With one exception,  the mice which received 2 mg of antiidiotypic IgG were 
suppressed  with  respect  to production  of  CRI; eight  of the  group were  com- 
pletely  suppressed,  one  was  partially  suppressed,  and  one  did  not  differ  sig- 
nificantly from controls. 
All mice which received 0.4 mg of antiidiotypic lgG were only partially sup- 
pressed or not suppressed  at all at the end of the 6 wk period,  as evidenced by 
the inhibitory capacity of serum from the first bleeding.  Those mice receiving 
0.04 mg showed little  evidence of suppression  (Table IV). 
LJect of  Variation  in  the  Time of Admil~islralion  of dntiidiotypic  Antibody 
Relalive lo that of Antigen.--In the experiments described above, and in previous 
work (2, 3), anti-D was injected at least 2 wk before antigen. A series of experi- 
ments was carried out in which the anti-D was given on days --14,  --7,  --3, 0, 
or q-3, with the time of injection of antigen denoted as day 0. The anti-D  (4 mg 
of an  IgG fraction)  was inoculated  subcutaneously in  saline  solution  and  the 
antigen  (KLH-Ar) was given intraperitoneally  in Freund's complete adjuvant. 
When the  two reagents  were given on the same day, antigen was injected im- 
mediately after  the anti-D.  A  second inoculation of antigen  was administered L.  L.  PAWLAK~  D.  A.  HART,  AND  A.  NISONOFF  1449 
TABLE  IV 
Variation  of dose of Antiidiotypic  IgG  Used for  Suppression  of Idiotype* 
Mouse no. 
7 mice 
s-n§ 
S-22 
S-23 
S-24 
S-25 
S-26 
S-27 
S-28 
S-29 
S-30 
S-32 
S-34 
S-35 
S-36 
S-37 
S-38 
S-40 
S-41 
S-42 
S -43 
S -44 
S-47 
$48 
S -49 
S-50 
6  mice 
controls 
Wt antiidiotypic  or 
nonspecific IgG 
mg 
4  (anti-D) 
2-(anti-D) 
0.4  (anti-D) 
0.04  (anti-D) 
4  (non-specific 
IgG) 
usI-labeled purified D antibody bound (% of control) 
Second bleeding  Third bleeding 
0.0~ 
95 
94 
93 
92 
42 
44 
92 
91 
72 
76 
91 
73 
68 
19-86, 
0.1 
24 
36 
62 
35 
31 
84 
33 
29 
18-3g 
#1 of serum tested as inhibitor 
l0 003  0, 
8  2:~  7  86 
32 
16 
27 
0 
0 
10 
9 
17 
0 
12 
0 
91 
61 
86 
II 
II 
19 
58  0 
II 
o 
40 
24 
19-22 
It 
71 
78 
73 
29 
70 
[I 
tl 
13 
27 
LI 
22 
It 
22 
15 
8-14 
61-94 
~6 
89 
91 
92 
93 
98 
I/ 
51 
73 
27 
14 
32 
II 
II 
8 
10 
51-82 
I[ 
84 
86 
t~ 
99 
LI 
86 
92 
99 
95 
[I 
10 
0 
I1 
3 
II 
0 
0 
* In the absence of inhibitor, 53%  (net value) of the labeled ligand was bound. All experi- 
ments were carried out in duplicate. The average deviation from the mean, expressed as per- 
cent of control was 4%. 
~: For mice injected with 4 mg of antiidiotypic or nonspecific IgG,  a range of values is given. 
§ Same as second footnote, Table I,  except that nonspecific or  antiidiotypic IgG  was ad- 
ministered subcutaneously, rather than i. p. 
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in Freund's complete adjuvant 17 days after the first. Test bleedings were taken 
10 days after fhe first inoculation of antigen and 7 days after the second. At the 
time of the second bleeding the sera of all mice gave strong precipitin lines in 
agar gel with the test antigen, BGG-Ar. No precipitin lines were observed with 
TABLE  V 
Variation  of  the  Time  of Administralion  of Anti-D  Rdative  to  that  of Antigen* 
I2~I-labeled purified anti Ar antibody bound (% of control) 
Time of  First bleeding  Second bleeding 
administration  Inhibitor  (mouse no.) 
of anti-D  #1 of serum tested as inhibitor 
1  10  0.1  1 
(~) 
day 
-7{ 
-7 
Controls 
12  mice  28  50§  6~20§ 
S-111  69  ¶1  ¶ 
S-2  74  86  74 
S-3  72  77  62 
S-4  89  94  90 
S-5  90  24  24  16 
S-6  99  40  20  6 
S-7  88  69  69 
S-8  94  75  65 
S-9  84  73  63 
SdO  84  ¶]  ¶ 
S-11  93  20  ¶  ¶1 
S-12  81  75  73 
S-13  90  16  12  4 
S-14  83  ¶  ¶ 
--3  Controls 
9 mice  20  40§  14-19§ 
1 mouse  74  20 
--3  S-31  89  0  0 
S-32  101  64  69  59 
S-33  102  34  49  17 
S-34  9O  73  68 
S-35  99  37  11  6 
S-36  83  76  73 
S-37  86  55  14 
S-38  87  19  ¶  ¶ 
S-39  94  75  56  22 
S-40  8O  8  3 
s-41  82  ¶  ¶ 
S-42  80  52  27 
S-43  96  76  ¶  ¶ 
S-44  31  13  0  0 L.  L.  PAWLAK~  D.  A,  HART~  AND  A.  NISONOFt  ~  1451 
TABLE  V--Continued 
Time of 
administration 
of anti-D 
Inhibitor (mouse no.) 
12~I-labeled purified anti-Ar antibody bound(%  of control) 
First bleeding  Second bleeding 
#1 of serum tested as inhibitor 
1  10  0.1  1  10 
(b) 
day 
o,  Controls§ 
14 mice  16-58§  5-18§ 
S-61l[  103  88  21  14 
S-64  84  54  30  9 
S-66  75  16  15  7 
S-67  96  80  60  55 
S-68  98  81  65  48 
S-69  101  78  79  74 
S-70  100  83  41  20 
S-71  99  76  19  12 
S-72  98  68  37  17 
S-73  98  84  73  55 
S-74  98  68  30  9 
+3  Controls 
11 mice  1649  8-37  0-25 
1 mouse  93  53  24 
+3  S-91  93  67  62  40  8 
S-92  70  15  ¶  ¶ 
S-93  25  6  25  24 
S-94  84  59  ¶  ¶ 
S-95  38  8  30  6 
S-96  76  41  44  24 
S-97  17  6  35  28 
S-98  42  12  42  27 
S-99  84  51  75  63  24 
S-100  23  7  ¶  ¶ 
S-101  58  12  54  23 
S-102  69  30  51  34 
S-103  50  8  37  26 
S-104  66  11  ¶  ¶ 
* In the absence of inhibitor, 50%  (net value) of the labeled ligand was bound. All experi- 
ments were carried out in duplicate. The average deviation from the  mean, expressed as per- 
cent of control, was 3%. 
The time of the first inoculation of antigen is designated as day 0. Antigen was injected 
again on day +10.  The number  --7 indicates that anti-D was administered 7  days before 
antigen. 
§ For the control mice, a  range of values is given. 
l[ The letter S designates a suppressed mouse, which had received 4 mg of antiidiotypic IgG. 
Control mice received 4 mg of nonspecific rabbit IgG. The protocol of immunization is given 
in the text. The nonspecific or antiidiotypic IgG was administered subcutaneously. 
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sera from the first bleeding although inhibition tests, which are more sensitive, 
showed the presence of cross-reactive idiotype in all nonsuppressed mice. 
The results are shown in Tables V a and V b. Data on those mice treated with 
anti-D 14 days before antigen are not tabulated; the 10 mice in that grot~p were 
all  suppressed  with  respect  to  the  formation  of  CRI,  in  confirmation  of  the 
results shown, for another similarly treated group, in Table I. As indicated in 
Table V a,  10  of  14  mice treated  with  anti-D  7 days before antigen  did  not 
possess significant titers of CRI at the time of the first bleeding (10 days after 
inoculation of antigen).  Of these  10 mice, all that survived to the time of the 
second bleeding were still suppressed  (Table V a). These results indicate that 
suppression may be somewhat tess effective when  anti-D is given at day --7, 
rather than day --14. 
The anti-D was considerably less effective in suppression when given on day 
-3  (Table V a). Although 10 of the 14 mice had not produced CRI at the time 
of the first bleeding,  all but 3  mice had  escaped suppression,  partially or en- 
tirely, by the time of the second bleeding. 
The results were much the same when anti-D was given on day 0 (Table V b). 
Many mice lacked CR1 at the time of the first bleeding; however, all but one 
mouse showed significant titers of CRI in the second bleeding. On the average 
the titers of CRI were somewhat lower than those of the control group, which 
had received 4 mg of nonspecific rabbit IgG in place of anti-D IgG. When the 
anti-D  was  given  3  days subsequent  to  antigen  there  was  little  evidence of 
suppression, even in sera of the first bleeding, and virtually none at the time of 
the second bleeding (Table V b). 
Tests were  carried  out  with  sera of the  latter  group of mice to determine 
whether  any  circulating  immunoglobulin  having  CRI  was  present  on  day 3 
before the administration of anti-D. 10 #1 of each  serum  failed  to  inhibit  sig- 
nificantly  the  binding  of  the  labeled  ligand  (purified  anti-Ar  antibody  of 
mouse  126) by its antiidiotypic antibodies. 
Thus,  for optimal  suppression  anti-D  must  be administered  at  least  2  wk 
before antigen. Its effectiveness is diminished at day --7 or --3. There is little 
suppressive effect when anti-D is given on day 0 and virtually no effect when it 
is administered 3 days after the antigen. 
A llempls lo Suppress Idiolype wilh Fab' or F(ab'),, Fragme~ls of An6idiolypic 
Antibody.--Table VI summarizes the results of experiments in which mice were 
pretreated with  Fab' or F(ab')z fragments of the IgG fraction of rabbit anti- 
idiotypic antibody that was used in the experinaents described above. Protocols 
were identical with those of the experiments summarized in Table IV. Thus, the 
first inoculation  of antigen  (500  ~g KLH-Ar)  was given 6  wk after the anti- 
idiotypic  Fab'  or  F(abr)2 fragments,  and  the  second  inoculation  2  wk  later. 
Freund's complete adjuvant was used for both injeclions. The mice were bled 
1 wk after the second inoculation. 
The results in Table VI indicate tbt  1.3 mg or 2.7 mg of F(ab')2 fragments, L.  L.  PAWLAK~  D.  A.  HART,  AND  A.  NISONOFF  1453 
TABLE  VI 
Effect of A dministratlon of Fab' or F (ab') 2 Fragments of A ntiidiotypic IgG on the Subsequent 
Production  of the Cross-Reactive A nti-A r Idiotype 
125 I-ligand bound 
Volume of 
No. of mice  Pretreatment  inhibitor*  % of controls 
(serum) 
Median  Range 
6 
7 
7 
15 
S 
17 
2 
gl 
4 mg RIgG§  0.1  20  18-39 
4 mg Anti-D (IgG)  10  81  79-86 
2.7 mg F(ab')e(RIgG)  0.1  25  18-32 
2.7 mg F(ab')2 Anti-D  0.1  21  9-37 
2.7 mg F(ab')2 Anti-D  O. 1  72  68-76 
1.0  19  19-20 
7  1.3 mg F(ab')2 Anti-D  0.1  21  13-38 
S 
9 
2  1.3 nag F(ab')2 Anti-D  0.1  78  67-88 
1.0  17  14--20 
7  2.7 mg Fab' RIgG  0.1  27  13-38 
14  2.7 mg Fab  t Anti-D  0. i  21  9-44 
5  1.3 mg Fab' Anti-D  0.1  21  18-28 
* IgG, Fab', or F(ab')2 fragments were administered  subcutaneously in  saline  6  wk  be- 
fore challenge with KLH-Ar. Inhibition tests were carried out with antisera obtained from 
the second bleeding, 3 wk after the start of immunization. 10/~1 of pooled normal A/J serum, 
tested as a control, caused less than 5% inhibition of binding. 
J~ In the absence of inhibitor, 53%  (net value) of the labeled ligand was bound.  Experi- 
ments were carried out in duplicate. The average deviation from the mean, expressed as per- 
cent of control, was 4%. 
§ RIgG, rabbit IgG. 
(equivalent  to  2  mg  or 4  mg,  respectively,  of IgG  with  respect  to  number  of 
combining  sites)  had  very little if any  suppressive  effect on the  appearance  of 
the cross-reactive idiotype.  1/zl of antiserum from all mice receiving the Fab' or 
F(ab')2  fragments  strongly  inhibited  the  binding  reaction,  whereas  10  /zl  of 
antiserum  from mice receiving the whole IgG fraction  of anti-D  antibody  was 
in each case not inhibitory. 
DISCUSSION 
When immunized with KLH-Ar all mice of the A/J strain investigated so far have 
produced  substantial  titers  of  anti-p-azophenylarsonate  (anti-Ar)  antibodies  with 
cross-reactive idiotypic specificities (CRI); antiidiotypic antisera prepared  in rabbits 
against  specifically purified anti-Ar antibodies from seven individual mice have been 
used in these studies. The CRI is in each case present on a  substantial fraction of the 1454  REQUIREMENTS  FOR  SUPPRESSION  OF  IDIOTYPE 
total anti-Ar antibody population, as shown by the low concentration needed for in- 
hibition of binding to its antiidiotypic antibodies of the labeled anti-Ar antibody used 
as the immunogen  (2, 8). Including those in the present study, more than 250 mice 
have been investigated. 
The presence of CRI in all immunized A/J mice made it possible to demon- 
strate  suppression  of  the  idiotypic specificity by inoculation  of antiidiotypic 
antibody prepared against the anti-Ar antibodies of individual mice (2, 3). In 
those investigations the initial challenge with antigen was made 2 wk (in adult 
mice) or 9 wk (in neonatal mice) after the antiidiotypic antibody. In each mouse 
this regimen resulted in the subsequent production of anti-Ar antibodies lacking 
CRI. The suppression persisted, in all but one mouse, for the duration of the 
experiment (up to 5 mo). In each mouse, however, anti-Ar antibodies appeared 
in substantial concentrations. Thus, the initial challenge with antigen resulted 
in the stimulation of clones of cells which were not producing CRI. It is con- 
ceivable, therefore, that antigen injected later, to determine whether suppres- 
sion had persisted, was captured by receptors on the cells  of these stimulated 
clones. Thus,  clones of cells capable of producing CRI,  even if they had  re- 
emerged, might not have been detected, owing to preferential capture of antigen 
by relatively large numbers of memory cells belonging to unrelated clones. 
To circumvent this possibility, the duration of suppression was investigated 
in the present study by varying the time interval between the administration of 
antiidiotypic IgG  and  the first challenge with antigen. Adult A/J mice were 
used in all experiments. 
When 4 mg of antiidiotypic IgG was injected, all mice were almost completely 
suppressed, with respect to the production of CRI, when challenged with anti- 
gen either 2 wk or 6 wk after inoculation of antiidiotypic IgG. When the first 
inoculation with antigen was given either 12 or 22 wk after the antiidiotypic 
IgG,  roughly half  of  the  mice in  each  group were  strongly suppressed  with 
respect to the production of CRI, a few other mice showed partial suppression, 
and some mice were not suppressed at all.  These data, together with our pre- 
vious results (2, 3),  indicate that suppression of CRI is maintained more ef- 
fectively if antigen is administered soon after anti-D. Nevertheless, a substan- 
tial proportion of the mice tested remained suppressed for 5 too, even without 
intervening  challenge with  antigen.  The  greater  suppression  in  previous ex- 
periments may have been due to stimulation by antigen of new clones of cells, 
producing anti-Ar antibody lacking CRI, which subsequently captured antigen 
and prevented the expression of reemerging clones capable of producing CRI. 
Variations in the dose of antiidiotypic IgG (Table IV) indicated that at least 
2 mg was required for substantial suppression of most mice and that 4 mg was 
somewhat more effective than 2 rag. Effective suppression was observed when 
the antiidiotypic antibody was administered either intraperitoneally (Tables I 
and II) or subcutaneously (Table IV), in each case without adjuvant. 
The  time  of administration  of  anti-D,  in  relation  to  that  of antigen,  was L.  L.  PAWLAK~  D.  A.  HART~  AND  A.  NISONOFF  1455 
found to be critical. When anti-D was given 2 wk before antigen,  each of the 
mice in  the group failed to produce  CRI. Suppression was somewhat less ef- 
fective when  anti-D  was administered  7 days before the  antigen;  about one- 
fourth of the mice produced CRI. Still less suppression was noted when anti-D 
was given 3  days before, or on the  same day as the antigen;  nearly all mice 
produced CRI, although in many the serum concentration was less than that of 
control mice. Little, if any suppression was observed when anti-D was injected 
3 days after the antigen. This is probably not attributable to simple absorption 
of the anti-D  by circulating anti-Ar antibody since no such antibody was de- 
tectable by the very sensitive inhibition-of-binding test just before administra- 
tion of anti-D. 
The fact that anti-D is ineffective when given 3 days after the antigen suggests that 
it cannot inhibit production of antibody once precursor cells have been triggered by 
antigen and the process of differentiation has begun. A similar effect was noted by 
Cosenza and Kohler (9) in their studies carried out in vitro. 
The fact that anti-D is ineffective when administered subsequent to antigen demon- 
strates that it does not suppress simply by absorbing D molecules, but rather exerts 
its effect on the  antibody-producing system. We had reached a  similar conclusion 
earlier (2) on the basis of the fact that control mice produce CRI in amounts far ex- 
ceeding  the capacity of the anti-D to absorb them, even if none of the anti-D were 
catabolized. It is of interest that X irradiation is also much less effective in suppressing 
an immune response when given subsequent to the antigen (10) ; this is attributable to 
rapid triggering of cellular  differentiation upon contact with antigen, and relative in- 
sensitivity of the differentiated cells to irradiation. 
Neither  Fab' nor  F(ab')2 fragments of antiidiotypic  IgG were  effective in 
causing  suppression.  No  significant  differences could  be detected  among the 
responses of mice administered nonspecific IgG or either Fab' or F(ab')2 frag- 
ments of antiidiotypic antibodies. The inactivity of Fab' or F(ab')2 might be 
related to their inability to fLx complement through the normal pathway. (We 
do not yet know, however, whether complement is required for inactivation of 
cells.  This  question  is  being investigated  through  experiments in  vitro.)  Al- 
ternatively, the fragments may be cleared so rapidly from the mouse that the 
concentration reaching the appropriate cell surfaces is too small to be effective. 
The half-life in the mouse of rabbit F(ab')2 or Fab fragments, is less than 0.5 
day,  as  compared  to  5.7  days for  rabbit  IgG  (11).  (The  half-life of  rabbit 
Fab  r in the mouse was not reported.) 
A  significant question  is whether  recovery from suppression is attributable 
to the reactivation of suppressed cells or to the generation of new cells capable 
of synthesizing molecules with CRI. One can rephrase the question by asking 
whether  antiidiotypic  antibodies  kill,  or  merely inactivate,  cells  bearing  re- 
ceptors with  CRI. In  the  case of immune suppression  of one  allotype of  an 
allelic  pair  in  rabbits,  fluorescent  staining  has  demonstrated  the  absence  of 
cells containing molecules of the suppressed allotype (12). Because of this and 1456  REQUIREMENTS  FOR  SUPPRESSION  OF  IDIOTYPE 
the  following  considerations  we  favor  the  possibility  of  elimination  of  cells, 
rather  than reversible inactivation,  as the basis of suppression.  (a) It is known 
that rabbit  antimouse Ig is capable of killing mouse B  cells in the presence of 
guinea pig complement (13).  (We could not find similar data for mouse comple- 
ment.)  (b)  The prolonged presence of a  heterologous immunoglobulin on a  cell 
surface might induce phagocytosis of the cell even if it did not kill it  directly. 
(c)  Regeneration  of surface determinants  after  cap formation  and pinocytosis 
appears unlikely as an explanation for escape from suppression, since regenera- 
tion occurs within  24 h  (14),  whereas the mice remained  suppressed  for much 
longer  periods  of  time.  Repeated  regeneration  of  idiotypic  determinants  fol- 
lowed  by  reaction  with  circulating  antiidiotypic  antibody  seems  conceivable 
but  unlikely,  especially  since  suppression  persisted  until  levels  of  circulating 
rabbit IgG must have been extremely low (11). 
One might inquire, then, as to why only half of the animals recovered in 12 or 22 wk. 
One possibility is that the regeneration of new precursors cells is a random process; the 
time required could vary greatly among individual mice. It is possible that all mice 
might recover in time. An alternative  hypothesis is that the antiidiotypic antibodies 
are capable of attacking immature stem cells, responsible for the eventual regeneration 
(over a  period of months)  of clones  producing CRI, and that  these  stem cells  were 
eliminated in some but not all suppressed mice.  (This assumes that the immediate pre- 
cursor cells are removed or inactivated in all suppressed mice.) 
The duration of suppression was less pronounced in these experiments than in previ- 
ous work, in which antigen was first administered 2 wk or 9 wk after antiidiotypic IgG 
(2, 3). In those studies, except for one mouse which did not appear to be suppressed at 
any time (3), all mice failed to produce CRI throughout lhe period of observation (2, 3, 
and unpublished data). In those experiments 15 mice survived for 3 mo and 9 for 5 mo. 
The escape of some mice from suppression after  12 wk in the present experiments is 
probably related  to the  fact that  antigen  was not administered  in the  interim;  the 
rationale for this was stated earlier in the Discussion. 
Adoptive transfer  experiments  in which  cells  are  treated  with  antiidiotypic 
antibody in vitro,  in  the  presence  or absence  of complement and  at  different 
temperatures,  should provide additional information  as to mechanisms of sup- 
pression and recovery. 
SUMMARY 
The appearance  of an idiotypic specificity, present  in  anu-p-azophenylarso- 
nate  (anti-Ar)  antibodies  of  all  immunized  A//J  mice,  can  be  suppressed  in 
adult  mice by prior  administration  of an  IgG fraction  of r;~bbit  antiidiotypic 
(anti-D)  antiserum;  anti-Ar antibodies  arise but are of different idiotype. Pro- 
longed suppression  was observed  in earlier  experiments,  but  antigen  was first 
administered  to adult  mice only 2  wk or 9  wk after  anti-D  antibodies;  subse- 
quent escape from idiotypic suppression could have been masked by the capture 
of  antigen  by large  numbers  of memory cells  having  receptors  of a  different L.  L.  PAWLAK~  D.  A.  HART~  AND  A.  NISONOFF  1457 
idiotype. In the present experiments antigen was first administered at intervals 
up to 22 wk after the antiidiotypic antibody.  Suppression was maintained  for 
6  wk in all  mice and for 5  mo in about half the mice tested.  It thus  appears 
that  suppression  of idiotype  is  less reversible  if  antigen  is  administered  soon 
after the antiidiotypic antibody. The data suggest that escape from suppression 
is attributable  to the generation of new precursor cells rather than to reactiva- 
tion of suppressed  cells. 
The minimum dosage of antiidiotypic IgG required for effective suppression 
was about 2 mg. The subcutaneous or intraperitoneal  routes of inoculation of 
antiidiotypic  IgG  were  equally  effective.  When  antiidiotypic  antibody  was 
administered  3 days after antigen no suppressive effects were observed. There 
was partial  suppression when antiidiotypic antibody was injected on the same 
day as  the  antigen.  Fab'  and  F(ab')2 fragments  of antiidiotypic IgG had  no 
suppressive  effect.  Quantitative  measurements  revealed  no  significant  differ- 
ences among control and suppressed mice with respect to total concentration of 
precipitable  anti-Ar antibodies produced. 
We are  grateful  to Mr.  Charles Munter,  Mr.  Geoff Morris,  and Mr.  John O'Brien  for 
competent  technical assistance. 
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